This undated photo made available by the Centers for Disease Control and Prevention shows a branch of the fungus Aspergillus fumigatus. The fungus can also cause skin infections if it enters a break in the skin. The meningitis outbreak is linked to the fungus being accidentally injected into people as a contaminant in steroid treatments. It’s not clear how the fungus got into the medicine.WASHINGTON – The chairman of the Senate’s health committee pledged Thursday to move ahead with legislation to tighten oversight of compounding pharmacies, amid a deadly outbreak caused by tainted specialty medications.
But a top lobbyist for the compounding industry, and some fellow senators, argued that existing state and federal laws could have prevented the wave of fungal meningitis that has killed 32 people.
In the second hearing on the issue this week, members of the Senate Committee on Health, Education, Labor and Pensions sought accountability for the contaminated steroid shots which have sickened more than 460 people in 19 states.
“This committee will forge ahead in developing legislation,” said committee chairman Sen. Tom Harkin, D-Iowa. But after more than three hours of testimony from federal and state regulators and industry representatives, there was little consensus on what form new regulations should take.
The International Academy of Compounding Pharmacists’ CEO David Miller condemned the New England Compounding Center, the company at the center of the incident, calling it “a pharmacy hiding behind that license and acting as an illegal drug manufacturer.”